These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population. Badings EA, Dyal L, Schoterman L, Lok DJ, Stoel I, Gerding MN, Gerstein HC, Tijssen JG. J Diabetes; 2011 Sep; 3(3):232-7. PubMed ID: 21631894 [Abstract] [Full Text] [Related]
48. Use of haemoglobin A1c to detect impaired fasting glucose or Type 2 diabetes in a United Kingdom community based population. Kumaravel B, Bachmann MO, Murray N, Dhatariya K, Fenech M, John WG, Scarpello TJ, Sampson MJ, University of East Anglia Impaired Fasting Glucose (UEA-IFG) Study Group. Diabetes Res Clin Pract; 2012 May; 96(2):211-6. PubMed ID: 22257419 [Abstract] [Full Text] [Related]
56. Variation in the relationship between fasting glucose and HbA1c: implications for the diagnosis of diabetes in different age and ethnic groups. Ram Y, Xu Y, Cheng A, Dunn T, Ajjan RA. BMJ Open Diabetes Res Care; 2024 Mar 04; 12(2):. PubMed ID: 38442986 [Abstract] [Full Text] [Related]
57. Increased arterial stiffness in subjects with pre-diabetes among middle aged population in Beijing, China. Shen L, Zhang YG, Liu M, Qiang DC, Sun XL, Liu L, Jiang YY. Biomed Environ Sci; 2013 Sep 04; 26(9):717-25. PubMed ID: 24099605 [Abstract] [Full Text] [Related]
59. Evaluation for fasting and 2-hour glucose and HbA1c for diagnosing diabetes based on prevalence of retinopathy in a Chinese population. Xin Z, Yuan MX, Li HX, Hua L, Feng JP, Shi J, Zhu XR, Cao X, Yang JK. PLoS One; 2012 Sep 04; 7(7):e40610. PubMed ID: 22808204 [Abstract] [Full Text] [Related]